Coronavac

CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus SARS-CoV-2 vaccine developed by Sinovac and extensively deployed globally to control the COVID-19 pandemic. Its use was highest in low- and middle-income countries. In January 2024, Sinovac confirmed that production of CoronaVac had been discontinued.